Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00p
  • 52 Week Low: 177.20p
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Friday broker round-up UPDATE

Date: Friday 09 May 2014

LONDON (ShareCast) - Advanced Medical Solutions: Numis ups target price from 105p to 121p and retains its hold recommendation.

Arrow Global: Numis upgrades from add to buy with a target price of 285p.

Bank of Georgia: Numis downgrades from buy to hold with a target price of 2708p.

Barclays: Citi lowers target price from 315p to 305p and maintains a buy recommendation. Numis upgrades from hold to add with a target price of 280p.

Britvic: Investec increases target price from 672p to 716p retaining its hold recommendation.

Centrica: Deutsche Bank cuts target price from 300p to 290p maintaining its hold recommendation.

Gemfields: Investec shifts target price from 40p to 42.5p retaining its buy recommendation.

Grafton Group: Investec ups target price from 690p to 710p upgrading from add to buy.

Greencore: Investec cuts target price from 285p to 273p downgrading from buy to add.

IMI: Jefferies lowers target price from 1750p to 1740p keeping a buy recommendation.

Intertek Group: Credit Suisse increases target price from 3200p to 3500p upgrading to outperform.

Johnston Press: Numis places its target price and its sell recommendation under review.

Keywords Studios: Numis raises target price from 180p to 205p and reiterates a buy recommendation.

Morgan Advanced Materials: Investec cuts target price from 415p to 395p, while leaving its buy recommendation unchanged.

Randgold Resources: Deutsche Bank ups target price from 4990p to 5000p and reiterates a buy recommendation. Numis reduces target price from 6200p to 5900p, while staying with its buy recommendation.

RPS Group: Panmure Gordon increases target price from 315p to 350p upgrading from hold to buy.

Sage Group: Credit Suisse moves target price from 347p to 360p maintaining an underperform rating.

Serco Group: UBS reduces target price from 400p to 300p and downgrades from neutral to sell.

Shire Pharmaceuticals: Citi raises target price from 4000p to 4100p and retains its buy recommendation.

SSE: Deutsche Bank cuts target price from 1360p to 1340p and keeps a hold recommendation.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00p
52 Week Low 177.20p
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page